Verisk

Verisk sells data, analytics and software to the insurance industry. Its underwriting products include the standard policy forms, rules and loss cost data that insurers use to write and price policies, and catastrophe models for storms and other events. Its claims products help insurers find fraud and estimate the cost of property repairs. Insurers pay for most of these products with subscriptions, which give about 84% of revenue.

The rest comes from transactions, such as reports bought one at a time. In Q3 2026, revenue was $809 million and adjusted EBITDA was $459 million. Verisk has data from many insurers over many decades, and the industry uses its forms and loss costs as a common standard.

The market fears that AI will reduce the value of Verisk's data and analytics, and that growth has slowed. Revenue growth fell from 7.5% in 2024 to 6.6% in 2025 and to 3.9% in Q1 2026, which management called the low point. A court case adds a second doubt. In August 2026, a Delaware court ruled that Verisk had no right to end its $2.35 billion purchase of AccuLynx, a roofing software company, and told it to make reasonable efforts to get antitrust approval.

Verisk appealed, and on October 23, 2026, the Delaware Supreme Court affirmed the ruling. The FTC asked for more information on the deal in 2025 and has not approved it, and Verisk bought back $1.9 billion of its shares in the first half of 2026 with cash and new debt, so a forced purchase adds debt. For the gap to close, three things must be true. Growth must return to the levels of the Investor Day targets, as management expects.

In Q3 2026, organic constant currency growth rose to 7.4% from 5.8% in Q2, and subscription growth was 8.2%. Insurers must keep buying Verisk's AI products, and subscription renewals must hold. The AccuLynx purchase must end with small costs, either by an FTC decision or by a settlement, and with no large damages. The next checks are the full-year 2026 report and 2027 guidance in early February 2027, and the FTC review of AccuLynx.

If growth recovers and the case ends, the gap can close over the next four to six quarters.

1. Oct 23, 2026Failed

   Delaware Supreme Court decision on AccuLynxA win on appeal, or a settlement with small costs, passes; a ruling that forces the $2.35 billion purchase with large damages or a long FTC fight fails.Outcome: The Delaware Supreme Court affirmed the Chancery Court ruling, so Verisk must work to get FTC approval and the $2.35 billion purchase can still go ahead.
2. Nov 5, 2026Passed

   Q3 2026 results: growth recoveryOrganic constant currency growth above the 5.8% of Q2 and subscription growth near 8% pass; growth that falls back toward the 3.9% of Q1 fails.Outcome: Organic constant currency growth rose to 7.4% and subscription growth was 8.2%, and Verisk kept its 2026 guidance.
3. Feb 5, 2027 · est.Pending

   Full-year 2026 results and 2027 guidance2027 guidance with growth at the Investor Day target levels passes; lower growth guidance or a weaker margin fails.
4. 2027 · est.Pending

   FTC review of the AccuLynx purchaseAn FTC decision or a settlement that ends the purchase obligation with small costs passes; a forced $2.35 billion purchase funded with more debt fails.

Every passed and failed checkpoint across all picks

• November 5, 2026Verisk reported Q3 2026 results. Revenue was $809 million, up 5.3%, or 7.4% on an organic constant currency basis. Subscription revenue grew 8.2% and transaction revenue grew 3.2%. Adjusted EBITDA was $459 million, a margin of 56.7%, and adjusted EPS was $1.96, up 14.0%. Free cash flow fell 40.5% to $200 million. Verisk started a $100 million accelerated share repurchase and kept its 2026 guidance.
• October 23, 2026The Delaware Supreme Court affirmed the Chancery Court ruling in the AccuLynx case. Verisk said that it will act in line with the court order. The $2.35 billion purchase still needs FTC review and other closing conditions, and Verisk said that it is not certain that the deal will close.
• October 1, 2026Verisk set November 5, 2026, before the market opens, as the date of its Q3 2026 results.

Last earnings

November 5, 2026 (8-K on sec.gov)

Next earnings

Expected about February 5, 2027. The company has not confirmed the date.

• 10-QQuarterly report for the period ended Sep 30, 2026Filed November 5, 2026 · Read it on sec.gov
• 8-KEarnings releaseFiled November 5, 2026 · Press release and exhibits
• 8-KOther company newsFiled October 29, 2026 · Read it on sec.gov
• 8-KChange of directors or officersFiled September 8, 2026 · Read it on sec.gov
• 8-KOther company newsFiled August 18, 2026 · Read it on sec.gov
• 10-QQuarterly report for the period ended Jun 30, 2026Filed July 29, 2026 · Read it on sec.gov
• 8-KEarnings releaseFiled July 29, 2026 · Press release and exhibits
• 8-KChange of directors or officersFiled July 28, 2026 · Read it on sec.gov
• 8-KShareholder vote resultsFiled May 21, 2026 · Read it on sec.gov
• 10-QQuarterly report for the period ended Mar 31, 2026Filed April 29, 2026 · Read it on sec.gov

Every filing on SEC EDGAR (CIK 1442145)

• The AccuLynx case can force Verisk to buy AccuLynx for $2.35 billion, a deal that the FTC questioned for harm to competition and has not approved. The appeal failed in October 2026, so Verisk must work to get approval, and it owes AccuLynx its direct costs plus interest. The deal adds debt after Verisk bought back $1.9 billion of shares in the first half of 2026. Legal fees already lowered profit in Q2 2026.
• AI tools can lower the value of insurance data and analytics, or let insurers and new companies build their own models. Verisk's shares fell by about half from their high by May 2026 on this fear. Longer sales cycles for AI products also slowed growth.
• Growth can stay slow. Revenue growth fell to 3.9% in Q1 2026 before it rose to 5.3% in Q3 2026, and transaction revenue depends on weather events and claims activity, which change from year to year.
• Management changes can slow execution. The Chief Information Officer left his role in August 2026, and the Chief Human Relations Officer will retire after a successor is found.

Verisk funds itself with unsecured senior notes of the parent company. At September 30, 2026, debt was $4,227.8 million of long-term debt, mainly senior notes due from 2029 to 2050, and $267.5 million of short-term debt, including $250 million on a 364-day term loan due February 19, 2027. Read more

Yield at the current rate

1.0% (current annual rate, at today’s price)

Dividend yield

0.9% (last 12 months, at today’s price of $205.98)

Paid per share

$1.95 in the last 12 months (4 payments)

Current annual rate

$2.00 ($0.50 × 4 a year)

Payout ratio

28% of the last fiscal year’s earnings (the year that ended December 31, 2025)

Latest ex-dividend date

September 15, 2026, $0.50 per share

Dividends per share by year

From 2020 to 2025, the dividend grew by about 10.8% a year.

Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.